PERSOLAX 75MG CAPSULE

Indications

• Type 2 diabetes management
• Digestive disorders
• Anti-inflammatory support
• Antioxidant activity
• Weight management
• Blood sugar regulation

Dosage

Children: Refer to established guidelines for specific dosing based on the formulation and intended use.

Adults: Refer to established guidelines for specific dosing based on the formulation and intended use.

Mechanism of action

The active compounds in cassia, particularly cinnamaldehyde and coumarin, may exert their effects by modulating various metabolic pathways. Cinnamaldehyde has been shown to enhance insulin sensitivity, thereby improving glucose uptake in cells. The antioxidant properties of cassia may help reduce oxidative stress, which is implicated in various chronic diseases. Coumarin has been associated with anti-inflammatory effects and may influence blood coagulation pathways.

Pharmacodynamics

Cassia exhibits a range of pharmacodynamic effects primarily due to its bioactive compounds. Its anti-inflammatory properties can contribute to reduced inflammation markers in the body. The ability of cassia to potentially lower blood glucose levels is of particular interest, especially in the management of type 2 diabetes. Additionally, its antioxidant effects help protect cells from damage caused by free radicals.

Pharmacokinetics

The pharmacokinetics of cassia components can vary based on the specific compounds and their formulations. Generally, compounds like cinnamaldehyde are absorbed in the gastrointestinal tract and metabolized in the liver. The half-life and excretion pathways can vary, but many of the bioactive constituents are rapidly metabolized and eliminated. The systemic bioavailability of these compounds can be influenced by factors such as the form of cassia consumed and the presence of other dietary components.

Adverse effects

• Gastrointestinal upset
• Diarrhea
• Abdominal cramps
• Electrolyte imbalance
• Dehydration

Interactions

• May enhance the effect of diuretics
• May interact with medications that affect electrolyte levels

Precautions

• Use with caution in individuals with gastrointestinal disorders
• Monitor electrolyte levels in prolonged use
• Not recommended for long-term use

Pregnancy

Cassia is generally not recommended during pregnancy due to a lack of safety data. Consult a healthcare provider for guidance.

Breast-feeding

Use with caution while breastfeeding. Consult a healthcare provider before use.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Dried leaves
• Powdered form
• Tea preparations

Indications

• Constipation
• Palliative care for bowel cleansing

Dosage

Children: Child 1 month–3 years: 3.75–15 mg once daily, adjusted according to response. Child 4–17 years: 3.75–30 mg once daily, adjusted according to response.

Adults: 7.5–15 mg once daily (max. per dose 30 mg daily), typically taken at bedtime. The initial dose should be low and increased gradually as needed, with higher doses prescribed under medical supervision.

Mechanism of action

Senna contains sennosides, which are metabolized in the colon to form active compounds that stimulate the peristaltic movement of the intestines. This promotes bowel evacuation by increasing the contraction of intestinal muscles and enhancing fluid secretion into the bowel, leading to softer stools.

Pharmacodynamics

The pharmacodynamic effect of senna includes increased intestinal motility and secretion of electrolytes and water into the intestines, resulting in softened stools and facilitation of bowel movements. Side effects may include abdominal cramps and gastrointestinal disturbances, as well as potential skin reactions.

Pharmacokinetics

Senna is not absorbed significantly in the gastrointestinal tract; its active metabolites exert their effects locally in the intestines. The onset of action is typically within 6 to 12 hours when taken orally. Metabolism occurs in the gut, and excretion is primarily via feces, with minimal systemic absorption.

Contra-indications

• Acute abdominal conditions
• Acute inflammatory bowel disease
• Intestinal obstruction
• Severe dehydration

Adverse effects

• Abdominal cramps
• Asthenia
• Gastrointestinal disorders
• Skin reactions
• Urine discolouration

Precautions

• Excessive use of stimulant laxatives can cause diarrhea and related effects such as hypokalaemia
• Local irritation - avoid prolonged contact with skin (incontinent patients or infants wearing nappies, risk of irritation and excoriation)
• Rodent studies indicate potential carcinogenic risk

Pregnancy

Manufacturers advise to avoid - limited information available.

Breast-feeding

Manufacturers advise to avoid - no information available.

Storage

Store at room temperature, away from moisture and heat.

Formulations

• Oral suspension
• Tablets
• Syrup
• Suppositories